Navigation Links
Polyhydroxyalkanoate Demand to Grow Significantly in Future, According to M&M Study Published at MarketPublishers.com
Date:9/26/2013

London, UK (PRWEB) September 26, 2013

Growing demand for biodegradable materials, governments’ positive attitude towards green purchasing policies, and surging oil costs are attracting a large number of companies to invest in the polyhydroxyalkanoate (PHA) market. Considering a broad range of possible applications and oncoming trends of biodegradable plastics, firms are expecting a remarkable hike in PHA demand in the forthcoming years. To date, high costs and performance issues are the major stumbling blocks for the PHA market.

Moving forward, an increase in PHA production is expected to be followed by a drop in prices for the product, which in turn will boost PHA demand in the years ahead. Most of the players are investing heavily into R&D for increasing the performance of their produced PHA in order to ensure that the new products developed are more distinguished and revolutionary in terms of features than the ones already available. Meredian Inc., Metabolix Inc., Biomer, Shenzhen Ecomann Technology Co. Ltd, and Tianjin GreenBio Materials Co. Ltd, among others, are the leading players in the global PHA marketplace.

Comprehensive research study “Polyhydroxyalkanoate (PHA) Market, By Application (Packaging, Food Services, Bio-medical, Agriculture) & Raw Material — Global Trends & Forecasts to 2018” elaborated by MarketsandMarkets (M&M) has been recently published by Market Publishers Ltd.

Report Details:

Title: Polyhydroxyalkanoate (PHA) Market, By Application (Packaging, Food Services, Bio-medical, Agriculture) & Raw Material — Global Trends & Forecasts to 2018
Published: May, 2013
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Global Demand for Pharmaceutical Regulatory Specialists Escalating Rapidly
2. Rising Interest in Molecular Biology Research Drives Demand for qPCR and dPCR Instrumentation, According to a Soon to be Released Report by Global Industry Analysts, Inc.
3. Bone Biologics Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. Global Medical Polymers Demand is Expected to Reach 6,411.7 kilo tons in 2018: Transparency Market Research
5. India Pharmaceutical Sector Reviewed by Kelly Scientific Publications in In-demand Report Now Available at MarketPublishers.com
6. Global Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: MarketResearchReports.Biz
7. Biovive M.D. Opens New Hormone Replacement Therapy Location in Boulder to Meet Community Demand
8. Marken Meets Critical Demand For In Vitro Lab Shipments
9. Veterinary Bioscience Institute Responds to Demand by Bringing Back Their Most Popular Webinar Series
10. Global Nano-Materials Market 2002-2016: Nano-Materials Industry, Production Volumes, Revenues and End User Market Demand - MarketResearchReports.Biz
11. "Eat-In" at FDA April 8 Demands Action on GMOs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Belmont, Mass. (PRWEB) August 27, 2014 ... of top technology vendors,” said Ven Thangaraj, CEO of ... imaging solutions that are taking the imaging corelab market ... trial sponsors, corelabs and research organizations to efficiently and ... and prepare the data to be analyzed and read ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com ... The Graphene Opportunity - A Rational View ... Graphene The New Nanotech? A similar amount ... of applications ranging from microelectronics to water treatment, ... announced the availability of the Graphene Opportunity Report, ...
(Date:8/27/2014)... 2014 Research and Markets has ... Pulp & Paper Industry Report 2014" report to ... Pulp & Paper Industry Report 2014 is a professional ... global enzyme for pulp & paper industry. ... including definitions, classifications, applications and industry chain structure. The ...
(Date:8/27/2014)... Aug. 27, 2014  ARCH Venture Partners, one ... in the development of seed and early-stage advanced ... fund closed with more than $400 million in ... million subscription target by more than $150 million. ... the strength and potential of our approach to ...
Breaking Biology Technology:Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Global Enzyme for Pulp & Paper Industry Report 2014 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3
... to Initiate Phase II Trial for IPLEX(TM) in ... Sweden, Sept. 23 ,Insmed Inc. (Nasdaq CM: INSM), ... Premacure AB, a biopharmaceutical company,dedicated to the development ... to premature birth, today noted the presentation of,clinical ...
... REDWOOD CITY, Calif., Sept. 23 Codexis, Inc., ... Vice President,Intellectual Property. She will be responsible for ... portfolio and will,report to Douglas Sheehy, Vice President, ... Codexis from Danisco A/S, where as Senior,Director, Intellectual ...
... 23 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc.,(TSX: SDI) today ... with Toray,Industries Inc. of Japan to obtain the ... Toraymyxin(TM), a therapeutic for the treatment of,sepsis that ... of the,agreement, the Company will seek FDA approval ...
Cached Biology Technology:Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 2Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 3Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 4Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 5Codexis Names Vice President, Intellectual Property 2Spectral to bring anti-sepsis therapy to the U.S. market 2Spectral to bring anti-sepsis therapy to the U.S. market 3
(Date:8/28/2014)... A new study reports that an expansion of marine ... perform key ecological functions. According to investigators from ... at protecting fish have focused on saving the largest ... species that provide key and difficult-to-replace ecological functions. ... are performed by fish species that also are food ...
(Date:8/28/2014)... Clinic researcher and his collaborators have developed an online ... process of re-engineering cells for biomedical investigation. CellNet is ... to aid stem cell engineering. Details of CellNet and ... two back-to-back papers in the journal Cell . ... uses for all types of cell-based investigations and can ...
(Date:8/28/2014)... on-off switch for Streptomyces , a group of ... world,s naturally derived antibiotic medicines. , Their hope ... to manipulate this switch to make nature,s antibiotic factory ... in Cell , found that a unique interaction ... protein called BldD ultimately controls whether a bacterium spends ...
Breaking Biology News(10 mins):Study finds marine protected areas inadequate for protecting fish and ocean ecology 2New tool aids stem cell engineering for medical research 2Small molecule acts as on-off switch for nature's antibiotic factory 2Small molecule acts as on-off switch for nature's antibiotic factory 3
... in their fight against a dangerous bacterium that sickens ... such as catheters, artificial joints and heart valves. , ... has, for the first time, been shown to protect ... would otherwise kill the bacteria, according to scientists at ...
... access publishing and the NIH new policy from ... of Health (NIH) rule on Enhanced Public Access to ... and a missed opportunity to take advantage of available ... the nation's leading not-for-profit medical and scientific publishers. The ...
... follow up of the NIH public access policy announced ... Central : , BioMed Central welcomes the announcement ... access policy. The NIH calls on all of its grantees ... National Library of Medicine's PubMed Central and make them freely ...
Cached Biology News:Substance protects resilient staph bacteria 2Not-for-profit publishers call NIH public access rule a missed opportunity 2Not-for-profit publishers call NIH public access rule a missed opportunity 3BioMed Central welcomes the new National Institutes of Health public access policy 2
... The ScriptCap™ 2'-O-Methyltransferase converts Cap 0 ... mRNA. The Cap 1 structure has been ... by up to 50%. This improvement is ... the ScriptCap™ m7G Capping System as well ...
Form: Concentrated Applications: ELISA...
Form: Ready to use Applications: ELISA...
RABBIT ANTI HALOPERIDOL...
Biology Products: